Tenderwize
Back to tender search

Open house Nilotinib discount agreements

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jan 04, 2027 · 141 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Nilotinib, ATC L01EA03 (ausgeschlossen Nilotinib dispergiert in Apfelmus, es sei denn, der Hersteller genießt hierfür Patentschutz)

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

No estimated value or volume data; actual discounts and market share impact unknown.

Open-house agreements automatically terminate if a competitive discount contract takes effect for the same substance.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Feb 2027
  • Pharmaceutical companies can enter into non-exclusive discount agreements with AOK Bayern for Nilotinib (ATC L01EA03).
  • Exclusion: Nilotinib dispersed in applesauce unless the manufacturer holds patent protection.
Show full summary

This is an open-house model (not a competitive tender) by AOK Bayern for non-exclusive discount agreements on Nilotinib (ATC L01EA03). Any eligible pharmaceutical company can join by submitting a signed declaration of reliability and a signed contract along with an annex listing the medicines. The agreement runs from 01.03.2025 to 28.02.2027, with possible termination with one month's notice. The open-house model is not subject to procurement law; the form is used only due to lack of a dedicated form. No estimated value is provided.

Risks

No estimated value or volume data; actual discounts and market share impact unknown.

Open-house agreements automatically terminate if a competitive discount contract takes effect for the same substance.

Key Requirements

Technical

  • Must be a pharmaceutical company.
  • Proof of authorization to sign (commercial register extract or power of attorney).

Administrative

  • Submit signed contract, signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and signed declaration of reliability.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Nilotinib discount agreements

Non-exclusive discount agreements for Nilotinib (ATC L01EA03), excluding Nilotinib dispersed in applesauce unless patent-protected. All interested pharmaceutical companies meeting eligibility can join. The contract is standard and non-negotiable.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Feb 2025 - Feb 2027

Category

Pharmaceutical products

Deadline

Deadline Jan 05, 2027

Procurement Details

Publication date
21 Jan 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
44907-2025

Documents (2)

Similar tenders